Chronic Myeloid Leukemia, Chronic Phase

Oncology
1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Terns Pharmaceuticals
Terns PharmaceuticalsFOSTER CITY, CA
1 program
1
TERN-701Phase 1/21 trial
Active Trials
NCT06163430RecruitingEst. May 2030

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
2028
2029
2030
Terns PharmaceuticalsTERN-701

Clinical Trials (1)

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

Start: Mar 2024Est. completion: May 2030
Phase 1/2Recruiting

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space